Qube Research & Technologies Ltd

Position in ALXO — Alx Oncology Holdings Inc

CIK 1729829 LONDON, X0

Position in ALXO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$215,832

+$184,821 QoQ

Shares Held

107,647

+535.2% QoQ

Ownership

0.080%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#29

of 68 holders

Holding Since

Dec 2021

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Qube Research & Technologies Ltd holds $2,033,804,065 across 186 Biotechnology names. ALXO ranks #156 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	838,187	$277,330,932
2	FOLD	AMICUS THERAPEUTICS, INC.	8,809,340	$127,383,056
3	ROIV	Roivant Sciences Ltd.	3,450,904	$95,590,040
4	RPRX	Royalty Pharma plc	1,524,511	$73,130,792
5	REGN	Regeneron Pharmaceuticals, Inc.	83,358	$64,405,725
6	AXSM	Axsome Therapeutics, Inc.	335,334	$56,678,152
7	RVMD	Revolution Medicines, Inc.	553,290	$53,807,452
8	CYTK	Cytokinetics Inc	779,446	$51,373,285

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$215,832	107,647	+535.2%	Shares	Sole	2026-05-15
2025-09-30	$31,011	16,946	-61.6%	Shares	Sole	2025-11-14
2025-06-30	$18,315	44,133	-70.0%	Shares	Sole	2025-08-14
2025-03-31	$91,566	146,977	+6.1%	Shares	Sole	2025-05-15
2024-12-31	$231,244	138,470	-69.7%	Shares	Sole	2025-02-14
2024-09-30	$833,044	457,717	+80060.6%	Shares	Sole	2024-11-14
2024-06-30	$3,443	571	-97.1%	Shares	Sole	2024-08-14
2022-09-30	$188,395	19,686	-77.1%	Shares	Sole	2022-11-14
2022-06-30	$696,532	86,098	+348.7%	Shares	Sole	2022-08-15
2021-12-31	$412,393	19,190	—	Shares	Sole	2022-02-10
No filing history on record for this holder in this stock.